Role of purgation therapy along with certain oral drug in the management of diabetic macular edema
Phase 2
- Conditions
- Health Condition 1: E113- Type 2 diabetes mellitus with ophthalmic complications
- Registration Number
- CTRI/2019/07/020089
- Lead Sponsor
- ational Institute of Ayurveda
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Open to Recruitment
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
1.Diagnosed cases of Diabetes Mellitus Type-II.
2.Mild to severe non-proliferative diabetic retinopathy with macular edema.
3.Visual acuity 6/60 to 6/9.
Exclusion Criteria
1.Visual acuity- less than 6/60.
2.Hypertensive patients with systolic BP >150 and diastolic BP >100 mm Hg.
3.Uncontrolled diabetic patients.
4.Pregnant diabetic patients.
5.Diabetic patients with other cardiovascular problems like CAD, Post MI, post CABG cases.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method reduction in macular edemaTimepoint: 3 months 15 days
- Secondary Outcome Measures
Name Time Method 1. Improvement in absolute and best corrected visual acuity. <br/ ><br>2. Improvement in color visionTimepoint: 3 months 15 days